tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Daniel Clark, 10 are a BUY (66.67%), 5 are a HOLD (33.33%).
Analyst Daniel Clark, currently employed at LEERINK, carries an average stock price target met ratio of 73.81% that have a potential upside of 10.73% achieved within 75 days.
Daniel Clark’s has documented 30 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ELAN, Elanco Animal Health at 24-Feb-2026.
Analyst best performing recommendations are on IDXX (IDEXX LABORATORIES).
The best stock recommendation documented was for IDXX (IDEXX LABORATORIES) at 7/17/2025. The price target of $600 was fulfilled within 18 days with a profit of $81.29 (15.67%) receiving and performance score of 8.71.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 29-Jan-2025
$26
$-0.37 (-1.40%)
$24
Buy Since 15-Oct-2018
$32
$5.63 (21.35%)
$15
Buy Since 19-Feb-2026
$30
$3.63 (13.77%)
$28
Buy Since 21-Nov-2025
$29
$2.63 (9.97%)
$27
Buy Since 05-Nov-2025
$30
$3.63 (13.77%)
$26
Which stock is Daniel Clark is most bullish on?
What Year was the first public recommendation made by Daniel Clark?
